NeuroVision Imaging
NeuroVision Imaging improves neurological screening and care by enabling earlier, noninvasive detection of Alzheimer’s-related amyloid pathology and streamlined patient triage. The company combines a telehealth platform (BrainHealth.net) with the Afina™ retinal imaging device and AI algorithms to analyze retinal scans for indicators of Alzheimer’s disease and cerebral amyloid angiopathy. NeuroVision operates as a B2B SaaS and telehealth services provider that partners with health systems, payors, labs, and pharma, and it also serves patients through diagnostic and biomarker testing. Its technology stack includes retinal imaging hardware, machine learning models, and telehealth software; the company holds multiple patents and has FDA 510(k) clearance and ISO 13485 certification. NeuroVision targets clinical and research markets to scale diagnostic access and support clinical trials and managed diagnostic services.
NeuroVision Imaging
NeuroVision Imaging improves neurological screening and care by enabling earlier, noninvasive detection of Alzheimer’s-related amyloid pathology and streamlined patient triage. The company combines a telehealth platform (BrainHealth.net) with the Afina™ retinal imaging device and AI algorithms to analyze retinal scans for indicators of Alzheimer’s disease and cerebral amyloid angiopathy. NeuroVision operates as a B2B SaaS and telehealth services provider that partners with health systems, payors, labs, and pharma, and it also serves patients through diagnostic and biomarker testing. Its technology stack includes retinal imaging hardware, machine learning models, and telehealth software; the company holds multiple patents and has FDA 510(k) clearance and ISO 13485 certification. NeuroVision targets clinical and research markets to scale diagnostic access and support clinical trials and managed diagnostic services.